Access the full text.
Sign up today, get DeepDyve free for 14 days.
Ho Lee, H. Park, B. Seo, J. Do, S. Yun, H. Song, Yeong‐Hoon Kim, Y. Kim, Dae-Joong Kim, Yong Kim, Curie Ahn, M. Kim, S. Shin (2005)
Superior Patient Survival for Continuous Ambulatory Peritoneal Dialysis Patients Treated with a Peritoneal Dialysis Fluid with Neutral pH and Low Glucose Degradation Product Concentration (Balance)Peritoneal Dialysis International, 25
K. Wieczorowska-Tobis, R. Brelińska, J. Witowski, J. Passlick–Deetjen, T. Schaub, H. Schilling, A. Bręborowicz (2004)
Evidence for Less Irritation to the Peritoneal Membrane in Rats Dialyzed with Solutions Low in Glucose Degradation ProductsPeritoneal Dialysis International, 24
(1995)
Renale Erkrankungen im Alter aus internistischer Sicht
T. Feest, J. Rajamahesh, C. Byrne, A. Ahmad, D. Ansell, R. Burden, P. Roderick (2005)
Trends in adult renal replacement therapy in the UK: 1982-2002.QJM : monthly journal of the Association of Physicians, 98 1
S. McDonald, G. Russ, P. Kerr, J. Collins (2002)
ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.American journal of kidney diseases : the official journal of the National Kidney Foundation, 40 6
(2000)
Zenchenko IV: Continuous ambulatory peritoneal dialysis in patients with diabetes mellitus
M. Zeier, V. Schwenger, R. Deppisch, U. Haug, K. Weigel, Udo Bahner, C. Wanner, H. Schneider, T. Henle, E. Ritz (2003)
Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?Kidney international, 63 1
F. Termorshuizen, J. Korevaar, F. Dekker, K. Jager, J. Manen, E. Boeschoten, R. Krediet (2003)
Time trends in initiation and dose of dialysis in end-stage renal disease patients in The Netherlands.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 18 3
O. Simonsen, G. Sterner, O. Carlsson, A. Wieslander, B. Rippe (2006)
Improvement of Peritoneal Ultrafiltration with Peritoneal Dialysis Solution Buffered with Bicarbonate/Lactate MixturePeritoneal Dialysis International, 26
J. Witowski, A. Jörres, K. Korybalska, K. Książek, J. Wiśniewska-Elnur, T. Bender, J. Passlick–Deetjen, A. Bręborowicz (2003)
Glucose degradation products in peritoneal dialysis fluids: do they harm?Kidney international. Supplement, 84
(1997)
Clinical and physiological effects of a new, less toxic and less acidic f luid for peritoneal dialysis
M. Krishnan, C. Lok, S. Jassal (2002)
Epidemiology and Demographic Aspects of Treated End‐Stage Renal Disease in the ElderlySeminars in Dialysis, 15
J. Niezgoda, A. Wolfson (1994)
Continuous ambulatory peritoneal dialysis.Emergency medicine clinics of North America, 12 3
J. Do, Yong-Lim Kim, Jong-Won Park, K. Cho, Tae-Woo Kim, K. Yoon, Chan-Duck Kim, Sun-Hee Park, J. Han, In-Han Song (2005)
The Effect of Low Glucose Degradation Product Dialysis Solution on Epithelial-To-Mesenchymal Transition in Continuous Ambulatory Peritoneal Dialysis PatientsPeritoneal Dialysis International, 25
J. Witowski, K. Korybalska, K. Książek, J. Wiśniewska-Elnur, A. Jörres, Cristina Lage, T. Schaub, J. Passlick–Deetjen, A. Bręborowicz, A. Grzegorzewska, A. Książek, T. Liberek, M. Lichodziejewska-Niemierko, M. Majdan, B. Rutkowski, T. Stompór, W. Sułowicz (2004)
Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 19 4
J. Marshall, P. Jennings, A. Scott, R. Fluck, C. McIntyre (2003)
Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS).Kidney international, 64 4
Bengt Rippe, Ole Simonsen, Olle Heimbürger, Anders Christensson, Börje Haraldsson, G. Stelin, Lars Weiss, Finn.-David. Nielsen, Susanne Bro, Michael Friedberg, A. Wieslander (2001)
Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products.Kidney international, 59 1
S. Nakai, T. Shinzato, T. Sanaka, K. Kikuchi, T. Kitaoka, T. Shinoda, C. Yamazaki, Rumi Sakai, Hiroyuki Omori, Osamu Morita, K. Iseki, K. Kubo, K. Tabei, I. Masakane, K. Fushimi, Atsushi Wada, N. Miwa, T. Akiba (2003)
The Current State of Chronic Dialysis Treatment in Japan(as of December 31, 2000) 1Therapeutic Apheresis and Dialysis, 7
K. Kasai, H. Terawaki, Y. Tanno, Y. Hara, M. Kondo, A. Hamaguchi, Y. Kawaguchi, T. Hosoya (1999)
[Factors influencing residual renal function of CAPD patients].Nihon Jinzo Gakkai shi, 41 7
V. Ermolenko, A. Melikiàn, M. Ivashchenko, E. Shutov, I. Zenchenko (2000)
[Continuous ambulatory peritoneal dialysis in patients with diabetes mellitus].Terapevticheskii arkhiv, 72 6
M. Baek, T. Kwon, Y. Kim, D. Cho (1997)
CAPD, an acceptable form of therapy in elderly ESRD patients: a comparative study.Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 13
B. Rippe, O. Simonsen, A. Wieslander, Christina Landgren (1997)
Clinical and Physiological Effects of a New, Less Toxic and Less Acidic Fluid for Peritoneal DialysisPeritoneal Dialysis International, 17
L. Cooker, Patricia Luneburg, D. Faict, C. Choo, C. Holmes (1997)
Reduced Glucose Degradation Products in Bicarbonate/Lactate-Buffered Peritoneal Dialysis Solutions Produced in Two-Chambered BagsPeritoneal Dialysis International, 17
S. Nakai, T. Shinzato, T. Sanaka, K. Kikuchi, T. Kitaoka, T. Shinoda, C. Yamazaki, Rumi Sakai, Hiroyuki Omori, Osamu Morita, K. Iseki, K. Kubo, K. Tabei, I. Masakane, K. Fushimi, Atsushi Wada, N. Miwa, T. Akiba (2002)
The current state of chronic dialysis treatment in Japan (as of December 31, 2000).Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 7 1
G. Stein, R. Fünfstück, R. Schiel (2004)
Diabetes mellitus and dialysis.Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 56 3
Baek My, K. Th, Kim Yl, Cho Dk (1997)
CAPD, an acceptable form of therapy in elderly ESRD patients: a comparative study., 13
Sun-Hee Park, Eun-Gyui Lee, In‐San Kim, Yong-Jin Kim, D. Cho, Yong-Lim Kim (2004)
Effect of Glucose Degradation Products on the Peritoneal Membrane in a Chronic Inflammatory Infusion Model of Peritoneal Dialysis in the RatPeritoneal Dialysis International, 24
K. Jager, P. Dijk, Friedo Dekker, Bénédicte Stengel, Keith Simpson, J. Briggs (2003)
The epidemic of aging in renal replacement therapy: an update on elderly patients and their outcomes.Clinical nephrology, 60 5
D. Frankenfield, B. Prowant, M. Flanigan, P. Frederick, G. Bailie, S. Helgerson, M. Rocco (1999)
Trends in clinical indicators of care for adult peritoneal dialysis patients in the United States from 1995 to 1997. ESRD Core Indicators Workgroup.Kidney international, 55 5
J. Witowski, J. Wiśniewska, K. Korybalska, T. Bender, A. Bręborowicz, G. Gahl, U. Frei, J. Passlick–Deetjen, A. Jörres (2001)
Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells.Journal of the American Society of Nephrology : JASN, 12 11
John Williams, N. Topley, K. Craig, R. Mackenzie, M. Pischetsrieder, Cristina Lage, J. Passlick–Deetjen (2004)
The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.Kidney international, 66 1
Carin Thorell, Natalia Muscalu, A. Andrén, P. Kjellstrand, A. Wieslander (1993)
Heat Sterilization of Fluids for Peritoneal Dialysis Gives Rise to AldehydesPeritoneal Dialysis International, 13
(1995)
Renale Erkrankungen im Alter aus internistischer Sicht . Diagnos - tik und Therapie
Introduction: Continuous ambulatory peritoneal dialysis (CAPD) treatment is subject to constant changes. Departing from this thesis, it should be analyzed in which respects CAPD treatment at the Heidelberg outpatient clinic has changed when considering demographic data, and CAPD-specific data including infection rates and clinical parameters. Materials and Methods: A retrospective study was carried out in the course of which a cohort of 67 CAPD patients treated before the year 2000 was compared with a cohort of 53 patients treated from the year 2000 on. Demographic data, CAPD-specific and clinical data at the commencement of treatment and data gathered during the observation period thereafter were recorded. Results: The patients of the more recent cohort were 5 years older. At the initiation of treatment, the volume of residual diuresis was higher in the patients treated from 2000 on than in those treated before. The blood pressure in patients belonging to the more recently treated group was also lower than the blood pressure of those treated before. The incidence of peritonitis and exit-site infections has decreased. On the other hand, the hemoglobin level has risen. Discussion: Compared to the past, many parameters have improved. Above all, the findings suggest that medical care and treatment have become better, probably as a result of the modified guidelines. The significant decrease in infections is probably also due to the use of the new dialysis fluids.
Nephron Clinical Practice – Karger
Published: Jan 1, 2008
Keywords: Peritoneal dialysis; Peritonitis; Dialysis solutions
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.